Who We Are

 

Scientists

Jessie Au, Pharm.D., Ph.D., Chief Scientific Officer and CEO

 

Dr. Au received her Pharm.D. and Ph.D. degrees from University of California

San Francisco and postdoctoral training at Roswell Park Cancer Institute. Dr. Au

is recognized for her accomplishments in pharmaceutical and cancer research.

Her breadth of interests and training in both clinical and basic sciences have

allowed her to excel in translating her laboratory discoveries in cellular and

molecular pharmacology of anticancer drugs into clinical applications.  Dr. Au is

among the top 5% recipients of NIH funding over 25 years.

 

Guill Wientjes, Ph.D., Principal Scientist

 

 

 

 

Ze Lu, Ph.D., Senior Research Scientist

 

Dr. Lu has been with Optimum since its inception and acts as Principal

Investigator on the tumor-penetrating microparticles (TPM) and paclitaxel

nanoparticles (PNP) projects.

 

 

 

 

 

Technicians